54
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids

, , &
Pages 157-167 | Published online: 20 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

C. Victor Spain, Parul Dayal, Yingjie Ding, Carlos Iribarren, Theodore A. Omachi & Hubert Chen. (2022) Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma. Journal of Asthma 59:6, pages 1237-1247.
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2014) Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 15:7, pages 961-977.
Read now
Mario Cazzola, Paola Rogliani, Lucia Novelli & Maria Gabriella Matera. (2013) Inhaled corticosteroids for chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:18, pages 2489-2499.
Read now
Mario Cazzola, Stefano Picciolo & Maria G Matera. (2010) Roflumilast in chronic obstructive pulmonary disease: evidence from large trials. Expert Opinion on Pharmacotherapy 11:3, pages 441-449.
Read now
Andrea S. Gershon, Li Wang, Teresa To, Jin Luo & Ross E.G. Upshur. (2008) Survival with Tiotropium Compared to Long-Acting Beta-2-Agonists in Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 5:4, pages 229-234.
Read now